DavidTWoodleyMD

USC Department of Dermatology

Dr. Woodley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1450 San Pablo St
Ste 2000
Los Angeles, CA 90033
Phone+1 323-442-6200

Fax+1 323-442-6299

University of North Carolina HospitalsResidency, Dermatology, 1976 - 1977
University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1974 - 1976
University of Missouri-Columbia School of MedicineClass of 1972

Use of Infliximab for the Treatment of Pemphigus Vulgaris Start of enrollment: 2006 Mar 01
Completed
Phase 2
Gentamicin for RDEB Start of enrollment: 2017 Feb 02
Completed
Phase 1, Phase 2
Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Start of enrollment: 2018 Jul 05
Recruiting
Phase 1, Phase 2
Gentamicin for Junctional Epidermolysis Bullosa Start of enrollment: 2018 Jun 01
Recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Join now to see all

PubMed

18 citations
Assessing hairdressers' knowledge of scalp and neck melanoma and their willingness to detect lesions and make referrals to dermatologists
Neda Roosta, David StC. Black, Michael Ka Keu Wong, David T. Woodley
Journal of the American Academy of Dermatology. 2013-01-01
1 citations
Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial.
David T Woodley, Michelle Hao, Andrew Kwong, Brandon Levian, Jon Cogan
The British Journal of Dermatology. 2024-07-16
43 citations
Thalidomide Increases Human Keratinocyte Migration and Proliferation
Maria Rita Nasca, Edel A. O'Toole, Prema Palicharla, Dennis P. West, David T. Woodley
The Journal of Investigative Dermatology. 1999-11-01

Lectures

Recent Advances in Bullous Diseases
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019
Reduced Intensity Conditioned Bone Marrow Transplant with Post-Transplant Cyclophosphamide and Donor-Derived Mesenchymal Stromal Cell Infusions for Recessive Dystrophi...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

Gentamicin Induces LAMB3 Nonsense Mutation Readthrough and Restores Functional Laminin 332 in Junctional Epidermolysis Bullosa
David Woodley, MD, Proceedings of the National Academy of Sciences
https://www.doximity.com/articles/91bfc536-08c3-4ecc-b418-84462b413a5a
UpToDate, Wolters Kluwer Health - 2012-11-27

IV Gentamicin Improves Junctional Epidermolysis Bullosa in ChildrenApril 1st, 2022
Now It Can Be Told! VMX Late-Breaking ResearchJune 18th, 2020
Improving Hairdresser’s Knowledge and Self-Efficacy to Detect Scalp and Neck Melanoma by Use of an Educational VideoFebruary 1st, 2020

Purification Of Epidermolysis Bullosa AntigenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998–2011
Protein Therapy For Recessive Dystrophic Epidermolysis BullosaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010
Mechanism Of Keratinocyte MotilityNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2009
Mechanisms Of Keratinocyte MotilityNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2003
Post Graduate Program In Cutaneous BiologyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1995–1998
Purification Of Epidermolysis Bullosa AntigenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1993–1998
Keratinocyte Locomotion And Protease ExpressionNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1996
Purification Of Epidermolysis Bullosa Acquisita AntigenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1989–1991
Characterization Of Edidermolysis Bullosa AntigenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1989
Purification Of Epidermolysis Bullosa Acquisita AntigenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1986–1989
Characterization Of Epidermolysis Bullosa AntigenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1985–1988
Purification Of Epidermolysis Bullosa Acquisita AntigenNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985